Children's National Research Institute
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Children's National Research Institute sits in the top decile of US sponsors by registered trial count (#256 of 15,742 sponsors by registered trial count).
Children's National Research Institute: 92 sponsored US clinical trials, 35 recruiting.
Children's National Research Institute sponsors 92 registered US clinical trials on ClinicalTrials.gov, 35 of them currently recruiting, and 41 completed. 5 of these trials are in Phase 3-4 (later-stage) and 18 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Sickle Cell Disease, with 3 trials.
Top-decile sponsor footprint
Children's National Research Institute ranks in the top decile of sponsors by registered trial count (#256 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
41 of 42 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (97.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
92 total, page 2 of 2
Interventions to Promote Well-being of Nightshift Nursing Team Members
NCT05722249
Feasibility Trial of a Mindfulness Based Intervention in Youth With Type 1 Diabetes
NCT05268393
Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors
NCT05302921
Group Visits for High Risk Type 1 Diabetes (T1D)
NCT05431686
Development and Pilot Testing of a Novel Preschool Executive Function Curriculum
NCT05135728
A Hybrid Effectiveness-implementation Trial of a High School-based Executive Function Treatment for Autistic Youth
NCT05017779
FACE for Children With Rare Diseases
NCT04855734
Hybrid Closed Loop in High Risk Youth With Type 1 Diabetes
NCT04807374
Sound Levels in the Pediatric Cardiac Critical Care Unit and Their Correlation With Sedation Administration, Delirium Scores and Patient Heart Rate
NCT04777695
Preliminary Feasibility and Efficacy of Behavioral Intervention to Reduce Pain-Related Disability in Pediatric SCD
NCT04388241
Accuracy of the Red Reflex Test in the Pediatric Population
NCT04125043
Concussion Active Rehabilitation
NCT04248218
Frameshift Peptides of Children With NF1
NCT04212351
Intermittent Hypoxia and Caffeine in Infants Born Preterm
NCT03321734
Infant Car Seat Use
NCT05252299
Improving Health Communication During the Transition From Pediatric to Adult Diabetes Care
NCT03734107
Hydroxyurea and Transfusion
NCT03644953
Social Navigation for Adolescents in ED
NCT03239041
PCORI Urea Cycle Disorder Study
NCT02740153
GPS (Giving Parents Support): Parent Navigation After NICU Discharge
NCT02643472
The Effects of Aromatherapy on the Incidence and Severity of Acute Pain
NCT03122574
Executive Function Intervention for High School Students With ASD
NCT03199937
Safety and Feasibility of MR-Guided High Intensity Focused Ultrasound (MR-HIFU) Ablation of Osteoid Osteoma in Children
NCT02349971
Improvement of STI Detection in Adolescent Emergency Department Patients
NCT02509572
MRI Assessment of Arrythmia Ablation Lesions
NCT02761343
Pilot Study of Cardiac MR in Patients With Muscular Dystrophy
NCT02921321
Palliative Care in People Living With HIV/AIDS: Integrating Into Standard of Care
NCT01775436
Cytotoxic T Cells to Prevent Virus Infections
NCT01923766
Myocardial Perfusion and Scarring in Adults With Congenital Heart Disease
NCT02861365
Bedside Lung Ultrasound in Young Children Presenting to the Emergency Department (ED) With Wheezing
NCT01452945
Fentanyl Metabolism in Obese Adolescents
NCT01955993
Oral Galactose in Children With Steroid Resistant Nephrotic Syndrome
NCT01113385
Improving Asthma Care Through Parental Empowerment
NCT00832923
Clinical Performance Evaluation of Pediatric and Neonatal Low Saturation Oximetry Sensors
NCT00843401
Magnetic Resonance Imaging (MRI) of Appendicitis in Children
NCT00723788
The Pharmacology and Hemodynamics of Dexmedetomidine in Children With Congenital Heart Disease
NCT00480740
Dexmedetomidine vs Fentanyl for BMT
NCT00654329
Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population
NCT00207935
Dexmedetomidine for Immediate Perioperative Analgesia in Pediatric Patients Undergoing Tonsillectomy
NCT00654511
Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents
NCT00207948
Prevalence of Proteinuria and Chronic Kidney Disease in Pediatric HIV-Infected Patients
NCT00153621
Pharmacokinetics, Safety and Tolerability of Zavesca (Miglustat) in Patients With Infantile Onset Gangliosidosis: Single and Steady State Oral Doses
NCT00672022
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 10 |
| Phase 2 | 8 |
| Phase 3 | 2 |
| Phase 4 | 3 |
What is open in the Children's National Research Institute pipeline
35 recruiting of 92 indexed (38% open); 41 completed (45%).
Phase mix: 5 late (III/IV) vs 18 early (I/II) (early-phase heavy).
Top condition: Sickle Cell Disease (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Children's National Research Institute: open-pipeline peers nationwide
Peers matched on 92 registered trials and 38% open enrollment, not the therapeutic-area sidebar.
Children's National Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 92 trials (± recruiting share)
- Drexel University · 92 trials · 16% recruiting
- Loyola University · 92 trials · 13% recruiting
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · 93 trials · 13% recruiting
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · 93 trials · 17% recruiting
Sponsors near 38% open enrollment (± trial volume)
- Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · 38% recruiting · 34 trials
- Intra-Cellular Therapies · 38% recruiting · 37 trials
- Morehouse School of Medicine · 38% recruiting · 13 trials
- Northeastern University · 38% recruiting · 39 trials
Related
What to do with this Children's National Research Institute page
92 registered trials is a research-attention snapshot, not an endorsement of Children's National Research Institute or any single study.
- 35 of Children's National Research Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Sickle Cell Disease is the condition Children's National Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Sickle Cell Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Children's National Research Institute pipeline card: 92 registered trials from official public datasets.Report a data error.